Informed Consent for Hematopoietic Stem Cell / Bone Marrow Transplantation

Section 1info grid
Section 2text block
Section 3text block
Section 4list block
Section 5list block
Section 6text block
Section 7text block
Section 8text block
Section 9text block
Section 10text block
Section 11text block
Section 12signature block

Informed Consent for Hematopoietic Stem Cell / Bone Marrow Transplantation

Patient and Transplant Information

Nature and Purpose of the Procedure

A hematopoietic stem cell transplant, commonly called a bone marrow transplant, is a complex medical procedure to replace damaged or diseased bone marrow with healthy stem cells. It is used to treat leukemia, lymphoma, myeloma, aplastic anemia, or severe immune deficiencies. The transplant has four main phases: (1) Conditioning: high-dose chemotherapy and/or Total Body Irradiation (TBI) to destroy cancer cells and clear out your existing bone marrow. (2) Infusion: the healthy donor or previously collected self stem cells are infused into your bloodstream through a central venous catheter, similar to a blood transfusion. (3) Engraftment: the stem cells travel to your bones and slowly begin producing new, healthy blood cells. This phase takes 2 to 4 weeks. (4) Recovery: intensive supportive care (blood transfusions, antibiotics, growth factors) while your immune system slowly recovers, which can take 6 to 12 months.

Transplant Type Details

The transplant plan is: [Patient's plan to be selected]. (1) Autologous transplant: uses your own stem cells that were collected and frozen earlier, before you received high-dose chemotherapy. The primary risk is cancer recurrence if cancer cells are present in the collected cells. (2) Allogeneic transplant: uses stem cells collected from a matched donor (sibling, unrelated donor, or umbilical cord blood). This carries the beneficial 'graft-versus-tumor' effect, where the new immune cells attack remaining cancer cells, but carries the risk of the new cells attacking your healthy tissues (Graft-versus-Host Disease).

Material Risks and Potential Complications

Graft-versus-Host Disease (GVHD - allogeneic only): occurs when the donor's immune cells attack your healthy organs (skin, liver, gut). Acute GVHD causes rash, severe diarrhea, and jaundice in 30 to 50 percent of patients. Chronic GVHD can develop months later, causing dry eyes, stiff joints, and lung damage. It requires long-term immune-suppressing medications.
Severe cytopenia and bleeding: the conditioning phase destroys all bone marrow. For weeks, your blood counts will be near zero. You will have a high risk of severe bleeding and will require frequent platelet and red blood cell transfusions.
Infections (neutropenic fever): because you will have no white blood cells during the engraftment phase, you will have a very high risk of life-threatening bacterial, viral, or fungal infections. You will be kept in a specialized protective isolation room and given prophylactic antimicrobial medications.
Organ toxicity: the conditioning regimen can cause severe damage to your lungs (pneumonitis), kidneys, and liver (veno-occlusive disease / sinusoidal obstruction syndrome, which is a blockage of small liver veins).
Infertility: high-dose chemotherapy and radiation almost always cause permanent infertility in both males and females. Options for fertility preservation must be discussed before starting conditioning.
Graft failure: the donor stem cells fail to grow and produce new blood cells. This is a rare (less than 3 percent) but life-threatening complication requiring emergency second transplants or growth factor therapy.

Alternatives to Transplant

Standard chemotherapy or targeted therapies: continuing lower-dose treatments to control the disease, accepting that they may not offer a permanent cure.
Clinical trials: participating in experimental drug or cellular therapy trials (e.g. CAR-T therapy).
Palliative and hospice care: focusing on quality of life and symptom management without transplant interventions.

Long-Term Care and Monitoring Commitment

A bone marrow transplant requires a significant personal commitment. You must remain close to the transplant center (within 30 to 60 minutes travel time) for at least the first 100 days after transplant. You must have a dedicated 24-hour caregiver during this time. You will need daily or weekly outpatient visits for blood draws, transfusions, and medication adjustments. You will be taking multiple medications, including immunosuppressants, to prevent GVHD, which must be taken exactly as prescribed.

Right to Withdraw Consent

You have the right to refuse the transplant. **IMPORTANT WARNING:** Once you begin the conditioning regimen (high-dose chemotherapy or radiation), your bone marrow is destroyed. Stopping the procedure after conditioning has started is fatal unless the stem cells are infused. Withdrawal of consent is only medically safe before the first conditioning dose is administered.

Patient Understanding and Questions

I confirm that I have read this document and understand the bone marrow transplant procedure, its phases, its significant risks (including GVHD, organ toxicity, and infertility), and the long-term caregiver requirements. All my questions have been answered.

Language Access

If English is not your primary language, a qualified interpreter is available at no cost. Please inform staff before signing.

Copy of Consent Acknowledgment

I acknowledge that I have been offered a copy of this signed consent form.

Patient Authorization

I voluntarily consent to undergo a hematopoietic stem cell / bone marrow transplant. I authorize the conditioning chemotherapy and radiation, the infusion of stem cells, the necessary blood transfusions, and the required inpatient and outpatient monitoring as described.

Signatures and Verification

Patient Signature
Oncologist Signature
Witness Signature
Date and Time of Consent
Document ID: CC-PENDING
CONSENTCOLLECT